Back to AMLX

Amylyx Pharmaceuticals, Inc. 8-K

Accession 0001193125-22-006731

Filing information

CIK
0001658551
Report date
2022-01-11
Filing date
2022-01-11
Form
8-K
Primary document
d273128d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.